Company intelligence / Profile preview

Access to Advanced Health Institute

Seattle, Washington, United Statesaahi.org ↗

Ownership: Private
Development stage: Phase 2

Overview

AAHI has reported encouraging results from its first-in-human trial of a temperature-stable tuberculosis vaccine candidate. The organization also received significant funding to develop a novel NanoAlum adjuvant formulation for improved protection against tuberculosis and pandemic influenza. Its chikungunya RNA vaccine program has advanced into Phase 1 clinical trials with support from major grants.

Therapeutic areas: Infectious Diseases
Modalities: VaccineAdjuvant formulation (including nanoparticle adjuvants)mRNA-based drugs
Industry: Academic Hospital/University/Research

Partnerships

Croda International plc (for innovation in vaccine development)Medical CBRN Defense Consortium/US government agenciesNational Institutes of Health (investor/grantor)The Chan Soon-Shiong Family Foundation (investor/grantor)

Beyond the preview

Go deeper on Access to Advanced Health Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Access to Advanced Health Institute.

Explore the full profile